DE69516519D1 - Wirkstoff gegen arteriosklerose - Google Patents

Wirkstoff gegen arteriosklerose

Info

Publication number: DE69516519D1
Authority: DE; Germany
Prior art keywords: proliferation; smooth muscle; muscle cells; vascular smooth; active against
Prior art date: 1994-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69516519T

Other languages

English (en)

Other versions

DE69516519T2 (de

Inventor

Hisao Tomioka

Hidefumi Ohsawa

Masao Moroi

T Kawashima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Tokyo Pharmaceuticals Inc

Original Assignee

Mitsubishi Tokyo Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-31

Filing date

1995-02-24

Publication date

2000-05-31

1995-02-24 Application filed by Mitsubishi Tokyo Pharmaceuticals Inc filed Critical Mitsubishi Tokyo Pharmaceuticals Inc

2000-05-31 Application granted granted Critical

2000-05-31 Publication of DE69516519D1 publication Critical patent/DE69516519D1/de

2000-10-12 Publication of DE69516519T2 publication Critical patent/DE69516519T2/de

2015-02-25 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

DE69516519T 1994-05-31 1995-02-24 Wirkstoff gegen arteriosklerose Expired - Fee Related DE69516519T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP11914694		1994-05-31
PCT/JP1995/000277 WO1995032714A1 (fr)	1994-05-31	1995-02-24	Depresseur de l'arteriosclerose

Publications (2)

Publication Number	Publication Date
DE69516519D1 true DE69516519D1 (de)	2000-05-31
DE69516519T2 DE69516519T2 (de)	2000-10-12

Family

ID=14754063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69516519T Expired - Fee Related DE69516519T2 (de)	1994-05-31	1995-02-24	Wirkstoff gegen arteriosklerose

Country Status (8)

Country	Link
US (1)	US5840741A (de)
EP (1)	EP0766963B1 (de)
KR (1)	KR970703147A (de)
AT (1)	ATE192040T1 (de)
AU (1)	AU702727B2 (de)
CA (1)	CA2190750A1 (de)
DE (1)	DE69516519T2 (de)
WO (1)	WO1995032714A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4171303B2 (ja) *	2001-02-26	2008-10-22	田辺三菱製薬株式会社	腎疾患・腎不全の予防剤及び／又は治療剤
US20070225301A1 (en) *	2006-02-13	2007-09-27	Astion Inflammation Aps	Treatment of acne and other diseases
KR20090106526A (ko) *	2006-12-18	2009-10-09	카르도스 아베	염증 질환 치료를 위한 새로운 조합
EP2107907B1 (de) *	2006-12-20	2012-02-01	Cardoz AB	Kombination von Pemirolast und Ramatroban zur Verwendung bei der Behandlung von entzündlichen Erkrankungen
WO2009007680A2 (en)	2007-07-11	2009-01-15	Cardoz Ab	Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
WO2009007673A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
WO2009007679A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007675A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
DE102014222804B4 (de)	2014-11-07	2023-12-28	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Vorrichtung und Verfahren zum Bestimmen einer Wandschubspannung und System zur Erkennung von Arteriosklerose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH9305A (en) *	1970-05-21	1975-08-18	H Hess	Trialkoxy quinazolines
JP3116970B2 (ja) *	1991-06-12	2000-12-11	三菱東京製薬株式会社	ペミロラストカリウムの徐放性製剤

1995
- 1995-02-24 US US08/737,680 patent/US5840741A/en not_active Expired - Fee Related
- 1995-02-24 EP EP95909975A patent/EP0766963B1/de not_active Expired - Lifetime
- 1995-02-24 DE DE69516519T patent/DE69516519T2/de not_active Expired - Fee Related
- 1995-02-24 KR KR1019960706787A patent/KR970703147A/ko not_active Application Discontinuation
- 1995-02-24 AU AU18239/95A patent/AU702727B2/en not_active Ceased
- 1995-02-24 AT AT95909975T patent/ATE192040T1/de not_active IP Right Cessation
- 1995-02-24 CA CA002190750A patent/CA2190750A1/en not_active Abandoned
- 1995-02-24 WO PCT/JP1995/000277 patent/WO1995032714A1/ja active IP Right Grant

Also Published As

Publication number	Publication date
AU702727B2 (en)	1999-03-04
CA2190750A1 (en)	1995-12-07
DE69516519T2 (de)	2000-10-12
KR970703147A (ko)	1997-07-03
WO1995032714A1 (fr)	1995-12-07
US5840741A (en)	1998-11-24
EP0766963A4 (de)	1997-10-29
EP0766963B1 (de)	2000-04-26
ATE192040T1 (de)	2000-05-15
AU1823995A (en)	1995-12-21
EP0766963A1 (de)	1997-04-09

Publication	Publication Date	Title
ATE370138T1 (de)	2007-09-15	Neue imidazopyridine und ihre verwendung
DE69410121D1 (en)	1998-06-10	Dihydro pyrazolopyrrole
TR200000129T2 (tr)	2000-07-21	Yepyeni spiroazabisiklik heterosiklik bileşikler.
TR199801642T2 (xx)	1998-11-23	Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
NZ325449A (en)	2000-01-28	Naphthyl-substituted benzimidazole derivatives as anticoagulants
HK1021699A1 (en)	2000-06-30	Pentafluorobenzenesulfonamides and analogs.
MY107341A (en)	1995-11-30	Novel hydroxamic acid and n-hydroxyurea derivatives and their use
SE9604786D0 (sv)	1996-12-20	New compounds
TR199802060T2 (xx)	1999-01-18	Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DE69519385D1 (de)	2000-12-14	Chinazolinon-arzneimittel sowie deren verwendung
IS7839A (is)	2004-05-23	4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
WO2001003685A3 (en)	2002-07-11	Novel prodrugs for antimicrobial amidines
NZ513096A (en)	2003-01-31	Compositions for treating inflammatory response
TR199902495T2 (xx)	2000-07-21	Bile�imler.
ATE161531T1 (de)	1998-01-15	Acridine-1,8-dionderivate als therapeutisches mittel
DE69516519D1 (de)	2000-05-31	Wirkstoff gegen arteriosklerose
BR0010693A (pt)	2002-02-05	Derivados azaindol para tratamento de depressão
MY133785A (en)	2007-11-30	Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
HUT70757A (en)	1995-10-30	Pharmaceutical compositions for treating skin disorders
ATE297926T1 (de)	2005-07-15	Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
EP1325918A4 (de)	2004-03-10	Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
EP0242230A3 (en)	1989-01-11	Pyrido û1,2-a¨ pyrimidine derivatives
CA2377226A1 (en)	2001-01-04	Benzimidazole compounds and medicaments comprising the same
SE9802650D0 (sv)	1998-07-31	Compounds
ATE81466T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.

Legal Events

Date	Code	Title	Description
2001-05-17	8364	No opposition during term of opposition
2002-02-28	8339	Ceased/non-payment of the annual fee